在Apo B100上氧化脂,血小板激活和活性以及长期心血管结果
Sotirios Tsimikas1, Alexander Kille2, Klaus Kaier3
1Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California San Diego (S.T., X.Y.).
Arteriosclerosis, thrombosis, and vascular biology
|August 14, 2025
概括
在apoB (OxPL-apoB) 上的氧化脂与心血管风险有关,但与血小板反应性无关. 升高的OxPL-apoB和Lp(a) 水平独立地预测了在接受冠状动脉血管造影的患者中无心肌梗塞的生存率.
科学领域:
- 心血管医学 心血管医学
- 临床研究 临床研究
- 生物化学 生物化学
背景情况:
- 在apoB (OxPL-apoB) 上的氧化脂含量,包括在脂蛋白上的脂含量,与心血管风险增加有关.
- 实验数据表明,OxPL在调节血小板功能方面可能发挥作用.
研究的目的:
- 调查OxPL-apoB与冠状动脉血管学患者的血小板反应性和长期心血管结果的相关性.
- 为了确定OxPL-apoB是否影响内在和克洛皮多格雷尔介导的血小板反应.
主要方法:
- 从EXCELSIOR试验中对2040名接受冠状动脉血管造影的患者进行观察性研究.
- 评估了与血小板激活标志物 (CD62P,CD41,PAC-1) 相关的OxPL-apoB水平以及对原和ADP的反应性.
- 利用考克斯回归模型评估OxPL-apoB和Lp(a) 与心肌梗塞无存活率和所有原因死亡率的关联,平均7年.
主要成果:
- 升高的OxPL-apoB与冠状动脉阻塞严重程度和心血管事件史相关.
- 在OxPL-apoB和内在或克洛皮多格雷尔诱导的血小板反应性之间没有发现显著的关联.
- 单独来看,OxPL-apoB和Lp(a) 都与无心肌梗塞的存活率较差有关,但当它们一起分析时,这种意义就消失了.
结论:
- 在接受冠状动脉血管造影的患者中,OxPL-apoB与血小板活性无关.
- OxPL-apoB和Lp (a) 之间的相互作用可能对确定长期心血管结果至关重要.
相关概念视频
01:30Atherosclerosis I: Introduction
82
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
82
01:26Coronary Artery Disease II: Pathophysiology
35
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
35
01:38Inflammation
55.1K
Overview
55.1K
01:31Lipid-derived Compounds in the Human Body
5.3K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
5.3K
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
293
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
293
01:26Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35